Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DTR Investments appears to be a private investment firm rather than a biotechnology, pharmaceutical, or healthcare operating company. Publicly available business-directory and company-database sources identify it as an active funding provider based in Florida, with at least one disclosed investment in MOTUS Consumer Insights. The available evidence does not indicate that DTR Investments develops therapeutics, operates a clinical pipeline, or provides life sciences products or services. Based on the accessible information, it should be classified as an investor with some exposure to healthcare-related portfolio activity, not as a health-focused drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DTR Investments.